首页> 美国卫生研究院文献>Current Developments in Nutrition >Benefits and Risks of Lowering Sodium Through Potassium-enriched Salt Substitution for Patients with Chronic Kidney Disease in China: A Modelling Study (OR25-05-19)

【2h】

Benefits and Risks of Lowering Sodium Through Potassium-enriched Salt Substitution for Patients with Chronic Kidney Disease in China: A Modelling Study (OR25-05-19)

机译：中国慢性肾脏病患者通过高钾盐替代降低钠盐的益处和风险：模型研究（OR25-05-19）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

ObjectivesPopulation-level replacement of discretionary (i.e, table/cooking) salt with potassium-enriched salt substitutes is a promising strategy to reduce blood pressure (BP) and prevent cardiovascular disease (CVD). This may be particularly impactful in countries like China where sodium intake is high, mainly from discretionary salt use, and where potassium intake low. However, hyperkalemia resulting from potassium-enriched substitutes and its adverse CVD consequences are of concern for those with chronic kidney disease (CKD). We aimed to estimate the benefits and risks of nationwide replacement of discretionary salt with potassium-enriched salt substitute on CVD mortality in Chinese CKD patients.

机译：目的用富含钾的盐替代品代替任意盐（即餐桌或烹饪用盐）的人群水平是降低血压（BP）和预防心血管疾病（CVD）的有前途的策略。这对像中国这样钠摄入量高的国家尤其有影响，这些国家的钠摄入量高，主要来自随意使用盐，钾摄入量低。然而，对于患有慢性肾脏病（CKD）的患者而言，富含钾的替代品引起的高钾血症及其对CVD的不利影响。我们的目的是评估在全国范围内用富钾盐替代品替代全民食用盐对中国CKD患者心血管疾病死亡率的益处和风险。

著录项

期刊名称 Current Developments in Nutrition
作者
Matti Marklund; Gitanjali Singh; Raquel Greer; Frederick Cudhea; Kunihiro Matsushita; Renata Micha; Tammy Brady; Di Zhao; Liping Huang; Maoyi Tian; Laura Cobb; Bruce Neal; Lawrence Appel; Dariush Mozaffarian; Jason Wu;
展开▼
作者单位

展开▼
年(卷),期 2019(3),Suppl 1
年度 2019
页码 OR25-05-19
总页数 1
原文格式 PDF
正文语种
中图分类营养学;
关键词

相似文献

外文文献
中文文献
专利

1. Prescribed Renoprotective Chinese Herbal Medicines Were Associated with a Lower Risk of All-Cause and Disease-Specific Mortality among Patients with Chronic Kidney Disease: A Population-Based Follow-Up Study in Taiwan [J] . Hsieh Chuan-Fa, Chang Huan-Cheng, Huang Song-Lih, Evidence-based complementary and alternative medicine: eCAM . 2017,第7期

机译：规定的慢性肾脏疾病患者的患者患有较低的全源和疾病特异性死亡风险的持续的肾上腺素药物：台湾的人口后续研究
2. Prevalence and risk factors for cardiovascular disease among chronic kidney disease patients: results from the Chinese cohort study of chronic kidney disease (C-STRIDE) [J] . Jun Yuan, Xin-Rong Zou, Si-Ping Han, BMC Nephrology . 2017,第1期

机译：慢性肾病患者心血管疾病的患病率和危险因素：中国队列慢性肾病（C-STRIDE）的研究结果
3. Importance and benefits of dietary sodium restriction in the management of chronic kidney disease patients: experience from a single Chinese center. [J] . Wang Yu, Sun Luying, Wang Haiyan, International Urology and Nephrology . 2012,第2期

机译：饮食中限制钠盐在慢性肾脏疾病患者管理中的重要性和益处：来自单个中国中心的经验。
4. A Markov Model Study on the Hierarchical Prognosis and Risk Factors in Patients with Chronic Kidney Disease [C] . Liu Xun, Lv Linsheng, Ling Li, Computer Science and Electronics Engineering (ICCSEE), 2012 International Conference on . 2012

机译：慢性肾脏病患者分层预后及其危险因素的马尔可夫模型研究
5. Risk Factors Associated with Chronic Kidney Disease of Unknown Etiology (CKDu): A Study of Patients from an Occupational Health Clinic in Rural Nicaragua [D] . Jimenez, Krystal A. 2016

机译：与未知病因慢性肾病相关的危险因素（CKDU）：尼加拉瓜农村职业健康诊所的研究
6. Prevalence and risk factors for cardiovascular disease among chronic kidney disease patients: results from the Chinese cohort study of chronic kidney disease (C-STRIDE) [O] . Jun Yuan, Xin-Rong Zou, Si-Ping Han, 2017

机译：慢性肾脏病患者中心血管疾病的患病率和危险因素：来自中国慢性肾脏病队列研究的结果（C-STRIDE）
7. Estimated population wide benefits and risks in China of lowering sodium through potassium enriched salt substitution: modelling study [O] . Matti Marklund, Gitanjali Singh, Raquel Greer, 2020

机译：通过富含钾替代的钠钠替代钠的人口广泛益处和风险：建模研究

Benefits and Risks of Lowering Sodium Through Potassium-enriched Salt Substitution for Patients with Chronic Kidney Disease in China: A Modelling Study (OR25-05-19)

摘要

著录项

相似文献

相关主题

期刊订阅